Biogen Inc. buy Royal Bank of Canada
Start price
05.06.24
/
50%
€215.30
Target price
05.06.25
€291.64
Performance (%)
-47.00%
End price
06.06.25
€114.10
Summary
This prediction ended on 06.06.25 with a price of €114.10. The BUY prediction by Royal_Bank_of_Canada for Biogen Inc. performed very badly with a performance of -47.00%. Royal_Bank_of_Canada has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 12.058% | 12.058% | -23.746% |
| iShares Core DAX® | 2.304% | 0.773% | 25.485% |
| iShares Nasdaq 100 | 1.287% | 5.575% | 18.707% |
| iShares Nikkei 225® | 0.404% | 6.122% | 9.461% |
| iShares S&P 500 | 1.202% | 3.625% | 12.145% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $317.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten